Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Share Analysis - Growth, Trends, and Forecasts (2024-2029)

The Advanced Therapy Medicinal Products (ATMP) CDMO Market Report is Segmented by Product (Gene Therapy, Cell Therapy, Tissue Engineering, and Other Products), Phase (Phase I, Phase II, Phase III, and Phase IV), Indication (Oncology, Cardiology, Neurology, Infectious Diseases, and Other Indications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value in USD for the Above Segments.

Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Share Analysis - Growth, Trends, and Forecasts (2024-2029)

Advanced Therapy Medicinal Products (ATMP) CDMO Industry Overview

The advanced therapy medicinal products (ATMP) CDMO market is moderately competitive, with several international players. Companies are involved in strategic activities like partnerships and collaboration to sustain the market. Some of the key players in the market include Catalent Inc., Lonza, WuXi Advanced Therapies, AGC Biologics, and CELONIC Group.

Advanced Therapy Medicinal Products (ATMP) CDMO Market Leaders

  1. Catalent, Inc.

  2. Lonza

  3. WuXi Advanced Therapies

  4. AGC Biologics

  5. CELONIC Group

  6. *Disclaimer: Major Players sorted in no particular order
Advanced Therapy Medicinal Products (ATMP) CDMO Market Concentration

Advanced Therapy Medicinal Products (ATMP) CDMO Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?